News Website

Natera Targets Endometrial Cancer With New Signatera Trial, Expanding Its MRD Opportunity - TipRanks

Natera Targets Endometrial Cancer With New Signatera Trial, Expanding Its MRD Opportunity TipRanks

Published: Jan. 14, 2026, 4:33 p.m.

Read Full Article

Mendelian randomization analysis of PKD1 in endometrial cancer and comparative multi-cancer study with renal cell carcinoma - springermedicine.com

Mendelian randomization analysis of PKD1 in endometrial cancer and comparative multi-cancer study with renal cell carcinoma springermedicine.com

Published: Jan. 14, 2026, 6:02 a.m.

Read Full Article

More people are living 5 years after cancer diagnosis, new ACS data shows - ABC7 New York

More people are living 5 years after cancer diagnosis, new ACS data shows ABC7 New York

Published: Jan. 13, 2026, 6:07 p.m.

Read Full Article

More people are living 5 years after cancer diagnosis, new ACS data shows - ABC7 Los Angeles

More people are living 5 years after cancer diagnosis, new ACS data shows ABC7 Los Angeles

Published: Jan. 13, 2026, 5:02 p.m.

Read Full Article

More people are living 5 years after cancer diagnosis, new ACS data shows - ABC30 Fresno

More people are living 5 years after cancer diagnosis, new ACS data shows ABC30 Fresno

Published: Jan. 13, 2026, 5:02 p.m.

Read Full Article

ASCO 2025: key highlights in endometrial cancer - springermedicine.com

ASCO 2025: key highlights in endometrial cancer springermedicine.com

Published: Jan. 13, 2026, 5:23 a.m.

Read Full Article

Molecular Profile–Based Adjuvant Treatment in High-Intermediate Risk Endometrial Cancer - The ASCO Post

Molecular Profile–Based Adjuvant Treatment in High-Intermediate Risk Endometrial Cancer The ASCO Post

Published: Jan. 12, 2026, 6:10 p.m.

Read Full Article

‘She’s Literally Busy Fighting Cancer:’ Howard Stern’s Sidekick Robin Quivers, 73, Expected to Continue On Radio Show But Will Focus On Cancer Treatment - SurvivorNet

‘She’s Literally Busy Fighting Cancer:’ Howard Stern’s Sidekick Robin Quivers, 73, Expected to Continue On Radio Show But Will Focus On Cancer Treatment SurvivorNet

Published: Jan. 11, 2026, 6:06 p.m.

Read Full Article

Novel Small Molecule Inhibitors Show Efficacy in Endometrial Cancer - Targeted Oncology

Novel Small Molecule Inhibitors Show Efficacy in Endometrial Cancer Targeted Oncology

Published: Jan. 11, 2026, 4:14 p.m.

Read Full Article

‘Guiding Light’ Soap Opera Actress Beth Chamberlin, 62, Says She Received a Hysterectomy After Endometrial Cancer Diagnosis – ‘I Didn’t Tell Anyone, Not Even My Family’ Until Now - SurvivorNet

‘Guiding Light’ Soap Opera Actress Beth Chamberlin, 62, Says She Received a Hysterectomy After Endometrial Cancer Diagnosis – ‘I Didn’t Tell Anyone, Not Even My Family’ Until Now SurvivorNet

Published: Jan. 10, 2026, 5:07 p.m.

Read Full Article

Latest Articles

Natera Targets Endometrial Cancer With New Signatera Trial, Expanding Its MRD Opportunity - TipRanks

Mendelian randomization analysis of PKD1 in endometrial cancer and comparative multi-cancer study with renal cell carcinoma - springermedicine.com

More people are living 5 years after cancer diagnosis, new ACS data shows - ABC7 New York

More people are living 5 years after cancer diagnosis, new ACS data shows - ABC7 Los Angeles

More people are living 5 years after cancer diagnosis, new ACS data shows - ABC30 Fresno

ASCO 2025: key highlights in endometrial cancer - springermedicine.com

Molecular Profile–Based Adjuvant Treatment in High-Intermediate Risk Endometrial Cancer - The ASCO Post

‘She’s Literally Busy Fighting Cancer:’ Howard Stern’s Sidekick Robin Quivers, 73, Expected to Continue On Radio Show But Will Focus On Cancer Treatment - SurvivorNet

Novel Small Molecule Inhibitors Show Efficacy in Endometrial Cancer - Targeted Oncology

‘Guiding Light’ Soap Opera Actress Beth Chamberlin, 62, Says She Received a Hysterectomy After Endometrial Cancer Diagnosis – ‘I Didn’t Tell Anyone, Not Even My Family’ Until Now - SurvivorNet

Subscribe to Our Newsletter